Moody’s Launches VIS Rating in Partnership with Vietnam’s Leading Financial institutions
NEW YORK–(BUSINESS WIRE)–Moody’s Corporation (NYSE:MCO) today announced the launch of Vietnam Investors Service And Credit…
NEW YORK–(BUSINESS WIRE)–Moody’s Corporation (NYSE:MCO) today announced the launch of Vietnam Investors Service And Credit…
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
LOS ANGELES–(BUSINESS WIRE)–Afterparty, the platform empowering thousands of creators with the tools and technology for…
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
PORTLAND, Ore.–(BUSINESS WIRE)–Columbia Sportswear Company (NASDAQ: COLM) (the “Company”), a global leading innovator in outdoor, active…
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
Conference Call and Webcast to be Held at 8:00 AM EDT / 2:00 PM CEST…
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) — HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company…
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
WOODCLIFF LAKE, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
— Two oral presentations and one poster will feature new data from the Company’s hepatitis…
— Two oral presentations and one poster will feature new data from the Company’s hepatitis…
SAN CARLOS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
SAN CARLOS, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage…
JERUSALEM, Sept. 19, 2023 (GLOBE NEWSWIRE) — via IBN – Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI),…
Mechelen, Belgium; 19 September 2023, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced…
NEW YORK & CHARLOTTE, N.C.–(BUSINESS WIRE)–Standard Chartered Americas (the “Bank”) today announced that it has…
Following Type C meeting feedback from the U.S. FDA, Taysha is discontinuing development of TSHA-120…
Company intends to make cash distributions currently estimated to be between $5 million and $7…